Clinical Updates

Various animals affected by H5N1 virus, including birds & dogs

May 30, 2024

Antibodies to Influenza A(H5N1) Virus in Hunting Dogs |
Cow’s Milk Containing Avian Influenza A(H5N1) Virus |
Risk Factors for Pediatric Critical COVID-19 |
The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights |
Durability of XBB.1.5 Vaccines against Omicron Subvariants |
Post-COVID Conditions Following COVID-19 Vaccination |
The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19 |
Cerebral Microstructural Alterations in Post-COVID-condition |
Prevalence and Co-occurrence of Cognitive Impairment in Children |
Long COVID Symptoms after 8-month Recovery

May 30, 2024 Read More »

COVID-19 pre-vaccine era illustration

May 23, 2024

Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period |
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 |
Cardiopulmonary Exercise Testing in Children with Long COVID |
Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) |
Potential Diaphragm Muscle Weakness-related Dyspnea Persists Two Years after COVID-19

May 23, 2024 Read More »

Vaccine vial labeled H5N1 virus

May 18, 2024

Virome Sequencing Identifies H5N1 Avian Influenza in Wastewater from Nine Cities | COVID-19 Vaccines and Adverse Events of Special Interest: A Multinational Global Vaccine Data Network (GVDN) Cohort Study of 99 million Vaccinated Individuals |
The Role of Colchicine in the Management of COVID-19: A Meta-analysis | Psychometric Analysis of the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a Prospective Multicentre Study

May 18, 2024 Read More »

Get Ready For Corona Vaccine

May 9, 2024

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 | Association of Nirmatrelvir–ritonavir with Post-acute Sequelae and Mortality in Patients |
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization |
Cognitive Profile in Multiple Sclerosis and Post-COVID Condition | Unravelling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID |
Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021

May 9, 2024 Read More »

Corona Vaccine

May 5, 2024

COVID-19 Booster Vaccine Uptake and Reduced Risks for Long-COVID |
COVID-19 Immunologic Antiviral Therapy with Omalizumab (CIAO)—a Randomized Controlled Clinical Trial | Abatacept Pharmacokinetics and Exposure Response in Patients |
The Gut Microbiome Associates with Phenotypic Manifestations |
Characteristics and Determinants of Pulmonary Long COVID |
Long COVID: Plasma Levels of Neurofilament Light Chain in Mild COVID-19 Patients with Neurocognitive Symptoms

May 5, 2024 Read More »

Corona Vaccine In Childrens

April 24, 2024

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 | Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen |
The Persistence of SARS-CoV-2 in Tissues and its Association with Long COVID Symptoms: A Cross-sectional Cohort Study in China

April 24, 2024 Read More »

Impact of SARS-CoV-2

April 17, 2024

Systematic Analyses of the Factors Influencing Sperm Quality in Patients with SARS-CoV-2 Infection |
Nirmatrelvir/ritonavir and Remdesivir against Symptomatic Treatment in High-risk COVID-19 Outpatients to Prevent Hospitalization or Death During the Omicron Era: A Propensity Score-matched Study |
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

April 17, 2024 Read More »

Corona Vaccine in Rural Area

April 11, 2024

Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 |
Brain and Cognitive Changes in Patients with Long COVID Compared with Infection-recovered Control Subjects | Incident Allergic Diseases in Post-COVID-19 Condition: Multinational Cohort Studies from South Korea, Japan and the UK |
Functional Limitations and Exercise Intolerance in Patients with Post-COVID Condition

April 11, 2024 Read More »

Covid Phase

April 3, 2024

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease |
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs |
Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases

April 3, 2024 Read More »

Covid Treatment

March 28, 2024

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment – A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study |
Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

March 28, 2024 Read More »

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top